Stocks and Investing
Stocks and Investing
Thu, September 12, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, September 11, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Hans Engel Upgraded (AZN) to Strong Buy on, Sep 11th, 2024
Hans Engel of Erste Group, Upgraded "AstraZeneca PLC" (AZN) to Strong Buy on, Sep 11th, 2024.
Hans has made no other calls on AZN in the last 4 months.
There are 3 other peers that have a rating on AZN. Out of the 3 peers that are also analyzing AZN, 0 agree with Hans's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Hans
- Steve Scala of "TD Cowen" Maintained at Strong Buy with Increased Target to $95 on, Monday, August 12th, 2024
- Jasper Hellweg of "Argus Research" Maintained at Strong Buy with Increased Target to $85 on, Thursday, May 30th, 2024
- Rajan Sharma of "Goldman Sachs" Initiated at Strong Buy and Held Target at $97 on, Thursday, May 30th, 2024
Contributing Sources